Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA276429
Max Phase: Preclinical
Molecular Formula: C19H34O5
Molecular Weight: 342.48
Molecule Type: Small molecule
Associated Items:
ID: ALA276429
Max Phase: Preclinical
Molecular Formula: C19H34O5
Molecular Weight: 342.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO
Standard InChI: InChI=1S/C19H34O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-18(21)23-16-14-19(22)24-17(16)15-20/h16-17,20H,2-15H2,1H3/t16-,17+/m1/s1
Standard InChI Key: ZAAPYHDKFLKBSV-SJORKVTESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 342.48 | Molecular Weight (Monoisotopic): 342.2406 | AlogP: 3.91 | #Rotatable Bonds: 14 |
Polar Surface Area: 72.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.63 | CX LogD: 4.63 |
Aromatic Rings: 0 | Heavy Atoms: 24 | QED Weighted: 0.38 | Np Likeness Score: 1.25 |
1. Lee J, Marquez VE, Lewin NE, Kazanietz MG, Bahador A, Blumberg PM. (1993) Conformationally constrained analogues of diacylglycerol (DAG). 3. Interaction of -alkyl--lactones with protein kinase C (PK-C), 3 (6): [10.1016/S0960-894X(00)80295-4] |
2. Lee J, Sharma R, Teng K, Lewin NE, Blumberg PM, Marquez VE. (1994) Conformationally constrained analogues of dag .8. Changes in PK-C binding affinity produced by isosteric groups of the 3-O-acyl function in 2-deoxy-L-ribonolactones, 4 (11): [10.1016/S0960-894X(01)80364-4] |
3. Sharma R, Marquez VE, Milne GW, Lewin NE, Blumberg PM. (1993) Conformationally constrained analogues of diacylglycerol. 5. 2,5-Dideoxy-3-O-tetradecanoyl-D-galactono-1,4-lactone: A superior homologue of 3-O-tetradecanoyl-2-deoxy-L-ribonolactone with PK-C binding affinity., 3 (10): [10.1016/S0960-894X(01)81002-7] |
4. Lee J, Lewin NE, Blumberg PM, Marquez VE. (1994) Conformationally constrained analogues of diacylglycerol. 9.1 the effect of side-chain orientation on the protein kinase C (PK-C) binding affinity of -lactones, 4 (20): [10.1016/S0960-894X(01)80399-1] |
5. Marquez VE, Lee J, Sharma R, Teng K, Wang S, Lewin NE, Bahador A, Kazanietz MG, Blumberg PM. (1994) Conformationally constrained analogues of diacylglycerol. 6. Changes in PK-C binding affinity for 3-O-acyl-2-deoxy-L-ribonolactones bearing different acyl chains., 4 (2): [10.1016/S0960-894X(01)80144-X] |
6. Lee J, Marquez VE, Lewin NE, Blumberg PM. (1994) Conformationally constrained analogues of DAG.7. Interaction of a medium-size -lactone with protein kinase C (PK-C)_, 4 (4): [10.1016/S0960-894X(01)80151-7] |
Source(1):